Navigation Links
Japanese Fund Moves Quickly to Invest in Promising Technology Against Malaria, Tuberculosis And Chagas Disease
Date:11/7/2013

TOKYO and NEW YORK, Nov. 7, 2013 /PRNewswire-USNewswire/ -- The Global Health Innovative Technology Fund (GHIT Fund), a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, announced today grants of US$5.7 million to six global partnerships working on innovative drugs and vaccines against malaria, tuberculosis and Chagas disease.

"Our six new investments in potential treatments for malaria, tuberculosis and Chagas disease, infections that afflict roughly one in seven of our world's population, are a definitive step forward for, and a clear exemplification of, Japanese innovation and its application to global health," said Dr. BT Slingsby, the CEO and executive director of the GHIT Fund. 

"By ending the vicious cycle of infections, poverty and destabilized communities, new drugs and vaccines for the poorest people in the world can bring stability and build new markets around the world," said Dr. Kiyoshi Kurokawa, the chair of the board of the GHIT Fund.

For malaria, a disease that sickens more than 200 million people each year and kills more than 650,000, the GHIT Fund will fund four new research and development (R&D) investments. The first is with the Research Institute for Microbial Diseases (RIMD) at Osaka University, in partnership with the Medical Center for Translational Research, Osaka University Hospital and Gulu University in Uganda, for roughly US$735,000 to test their newly formulated BK-SE36 malaria vaccine. A recently published study revealed that the vaccine showed efficacy against severe malarial infections, making it a promising malaria vaccine candidate. In the initial trials in a malaria-prone region of Uganda, however, many vaccinated adult individuals failed to generate a strong
'/>"/>

SOURCE Global Health Innovative Technology Fund (GHIT Fund)
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Japanese Market for Orthopedic Soft Tissue Repair & Sports Medicine
2. The Japanese Cancer Association and Debiopharm Group Present Doctors Oshima and Tanaka with the 2012 JCA-Mauvernay Award for their Innovative and Outstanding Cancer Research
3. Immunomic Therapeutics Begins Phase I Japanese Red Cedar JRC-LAMP-Vax Vaccine Safety Study
4. Neuland Labs Strengthens Commitment to Japanese Market With New Manufacturing Collaboration With Mitsubishi Healthcare Unit API Corporation
5. Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy
8. Japanese Heart Valve Device Market Growth Will Spike With The Launch of Transcatheter Heart Valves
9. The Japanese Market For Peripheral Vascular Devices Will Be Characterized By New Product Launches In Many Segments
10. The Japanese Embolization Particle Market Will Witness Significant Market Activity And Rapid Growth Due To New Product Approvals
11. SMT C1100 For Duchenne Muscular Dystrophy Moves To Human Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
... 10 Eli Lilly and Company (NYSE: LLY ... the Second Circuit has agreed with Lilly,s position that a ... payor suit, in which unions and insurers who act as ... court also agreed with Lilly that plaintiffs, overpricing claims should ...
... (NYSE Amex: PTN ) announced that it will ... Conference / 12th Annual Healthcare Conference on Tuesday, September 14, ... September 12-15 at the New York Palace Hotel in New ... Chief Executive Officer of Palatin Technologies, will provide an update ...
Cached Medicine Technology:U.S. Court of Appeals Reverses Third-Party Payor Class Certification Suit Against Lilly 2
(Date:4/17/2014)... pain relief targets that could be used to ... King,s College London made the discovery when researching ... of the body. , Dr Marzia Malcangio said: ... pain generation and our findings could help chemotherapy ... One potential side effect of some chemotherapy drugs ...
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... created a new technology for modifying human cells ... body and selectively target cancer and other sites ... monitor and modify human physiology is a promising ... technology enabled bioengineers to build such devices that ... a customized fashion. , "The project addressed a ...
(Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
Breaking Medicine News(10 mins):Health News:New pain relief targets discovered 2Health News:The ilk of human kindness 2Health News:Building 'smart' cell-based therapies 2Health News:Is Parkinson's an autoimmune disease? 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3
... effects, is serious enough to be considered a health risk. ... or fewer hours were more likelier to have a heart ... too much sleep isn't good, either, as researchers found that ... also increased their heart disease risk. ,The study, conducted ...
... rate for potential medical problems, according to earlier studies, is ... for babies in hospitals are even higher. However, a new ... Agency for Healthcare Research and Quality (AHRQ) may help prevent ... is aimed at pediatricians and parents, and includes a fact ...
... the United States have found that the practice of ... past 14 years. However, they suggested that patients with ... Pylori(H.Pylori) infection rather than receiving treatment for the infection ... appropriate option// than empiric treatment in patients with peptic ...
... wasting condition which is a serious problem in people with ... bowel, liver, lungs and heart. A recent study has found ... in fruit flies, where it is involved in muscle development, ... ,Researchers have been studying the function of the twist ...
... has identified independent factors that are associated with ... the study, information was gathered from the 1999 ... evaluate common factors in 1,810 diabetic Americans.// ... were found to have more primary care and ...
... The myth that eating nuts makes one fat has ... mono and polyunsaturated fats are good while simple carbohydrates ... low-density lipoprotein cholesterol, the good kind. Monounsaturated fat does ... in heart disease. ,Preliminary evidence shows that even ...
Cached Medicine News:
Designed to meet the demands of today's laboratories for RO water....
... L/day of Type III Laboratory-grade Water, RiOs ... up to 8000 L/day of Type III ... Complete Purification and Control Unit, RiOs systems ... providing total control of all parameters within ...
... RiOs systems produce Type III, laboratory-grade ... Systems are fed directly with potable tap ... a compact system design that is easy ... over the water produced at a low ...
... Model U410 is an upright freezer ... our Innova line, but using conventional ... a cost-effective alternative. Similar in size ... 240 2" boxes. Includes five compartments ...
Medicine Products: